Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;144(7):1309-1315.
doi: 10.1007/s00432-018-2663-z. Epub 2018 May 14.

The prognostic role of HBV infection in chronic lymphocytic leukemia

Affiliations

The prognostic role of HBV infection in chronic lymphocytic leukemia

Jin-Hua Liang et al. J Cancer Res Clin Oncol. 2018 Jul.

Abstract

Purpose: We attempt to assess the impact of hepatis-B virus (HBV) status on the prognosis of chronic lymphocytic leukemia (CLL) using a Chinese case cohort.

Methods: Five hundred and one consecutive newly diagnosed subjects with CLL were enrolled in this case cohort. HBV infection was defined as hepatitis B surface antigen (HBsAg) positive or hepatitis-B core antibody (HBcAb) positive. Univariate and stepwise multivariate Cox regression analyses were used to screen the prognostic risk factors associated with the end point of time-to-treatment (TTT) or overall survival (OS). Bootstrap re-sampling method was used to evaluate the model's internal validity. The discriminative ability of the models was evaluated using time-dependent receiver-operator characteristic (ROC) curves and corresponding areas under the curve (AUC).

Results: One hundred and twenty-one subjects (24%) among 501 patients were HBV positive. HBV infection was an independent predictor for the prognosis of TTT (HR = 1.37; 95% CI 1.04-1.80) or OS (HR =2.85; 95% CI 1.80-4.52). The AUCs for HBV infection were 0.62 (95% CI 0.58-0.66) for TTT and 0.69 (95% CI 0.66-0.72) for OS, respectively. When we combined HBV infection with the traditional clinical and biological factors, significant improvements for model's discrimination were observed for TTT [AUC: 0.81 (95% CI: 0.77-0.85) vs. 0.78 (95% CI: 0.74-0.82), P < 0.001] and OS [AUC: 0.81 (95% CI 0.76-0.86) vs. 0.76 (95% CI 0.71-0.82), P < 0.001). Further bootstrap re-sampling method revealed good internal consistence for the final optimal models (Average AUC: 0.78 for TTT and 0.79 for OS based on 1000 bootstraps).

Conclusions: Our results indicated that HBV infection should be served as an important risk predictor for prognosis of CLL (TTT and OS).

Keywords: Chronic lymphocytic leukemia; HBV; Overall survival; Prognostic biomarker; Time to first treatment.

PubMed Disclaimer

Conflict of interest statement

These authors have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Time-dependent ROC analysis for HBV-infection state and Models-1, -2 and, -3
Fig. 2
Fig. 2
TTT and OS for all the patients

References

    1. Binet JL, Auquier A, Dighiero G et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198–206 - PubMed
    1. Bulian P, Rossi D, Forconi F et al (2012) IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. J Transl Med 10:18 - PMC - PubMed
    1. Chen MH, Hsiao LT, Chiou TJ et al (2008) High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s Lymphoma. Ann Hematol 87:475–480 - PubMed
    1. Cheson BD, Bennett JM, Grever M et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87:4990–4997 - PubMed
    1. Cortese D, Sutton LA, Cahill N et al (2014) On the way towards a ‘CLL prognostic index’: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia 28:710–713 - PubMed

LinkOut - more resources